Ascendis Pharma A/S (ASND)

227.87 +0.56 (+0.25%) USD  |  NASDAQ  |  Oct 02, 16:00
227.96 +0.09 (+0.04%) After-Hours: 20:00
More

Ascendis Pharma Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for ASND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Annual Revenue Estimates Data

View and export this data back to 2024. Start Trial.
Date Value
December 31, 2028 --
December 31, 2027 --
December 31, 2026 --
Date Value
December 31, 2025 --
December 31, 2024 --

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
BioMarin Pharmaceutical, Inc. Upgrade
Novo Nordisk A/S Upgrade
Evaxion AS Upgrade
Genmab A/S Upgrade
Zealand Pharma A/S Upgrade